Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 7Thoracic 3Dermatologic 3Gynecologic 2Genitourinary 2CNS 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Melanoma 68Skin Neoplasms 15Neoplasm Metastasis 14Lymphoma, T-Cell, Cutaneous 9Carcinoma, Renal Cell 8Carcinoma, Non-Small-Cell Lung 8Breast Neoplasms 8Neoplasms 7Lymphoma 7Ovarian Neoplasms 6Mycosis Fungoides 6Kidney Neoplasms 6Colorectal Neoplasms 6Carcinoma, Merkel Cell 6Uveal Melanoma 5Uterine Cervical Neoplasms 5Sezary Syndrome 5Multiple Myeloma 5Esophageal Neoplasms 5Carcinoma, Hepatocellular 5Stomach Neoplasms 4Sarcoma, Synovial 4Pancreatic Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Lymphoma, Non-Hodgkin 3

Interventions

pembrolizumab 4Cyclophosphamide 4fludarabine 3Nivolumab 3Ipilimumab 3Drug Therapy 3aldesleukin 2Biopsy 2utomilumab 1trastuzumab deruxtecan 1sargramostim 1poly ICLC 1liposomal doxorubicin 1fludarabine phosphate 1erythromycin propionate-N-acetylcysteinate 1enzalutamide 1durvalumab 1brodalumab 1atezolizumab 1advexin 1Sirolimus 1Radiotherapy, Conformal 1Quality of Life 1Psychology, Positive 1Poly I-C 1Patient Reported Outcome Measures 1Observation 1National Cancer Institute (U.S.) 1Molecular Diagnostic Techniques 1Microscopy, Electron 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Liver Neoplasms × fludarabine × Dermatologic × Clear all
NCT07410494 2026-02-18

SELECT-CAR-NK

Essen Biotech

Phase 1/2 Recruiting
85 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT02869217 2025-12-03

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

University Health Network, Toronto

Phase 1 Active not recruiting
22 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Synovial

NCT01967823 2021-03-24

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
11 enrolled 12 charts
BreastCNSDermatologicGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Melanoma, Meningioma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡